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Abstract- This paper presents an Ontology-based Holonic Diagnostic System (OHDS) that 
combines the advantages of the holonic paradigm with multi-agent system technology and 
ontology design, for the organization of unstructured biomedical research into structured 
disease information. We use ontologies as ‘brain’ for the holonic diagnostic system to 
enhance its ability to structure information in a meaningful way and share information 
fast. To integrate dispersed heterogeneous knowledge available on the web we use a fuzzy 
mechanism ruled by intelligent agents, which automatically structures the information in 
the adequate ontology template. Our vision of how this system implementation should be 
backed by a solid security shield that ensures the privacy and safety of medical 
information concludes the paper.   
 Keywords- Human disease ontology template, internet-enabled diagnosis, heterogeneous 
knowledge integration, soft computing agents, secure health information systems, control 




In today’s global world fast and reliable medical diagnosis is of vital importance as can be seen, for 
example, from the recent problems with SARS or the bird flu. Such highly contagious and lethal diseases can 
threaten the world if they are not fought immediately and with high efficiency and reliability. However, to do 
so, it is, first of all, necessary to quickly and surely diagnose the disease regardless of where the case is 
encountered in the world. While, after a short while, the identification of the disease at its hot spots may 
become routine, its diagnosis at more remote/unlikely places will remain the challenge. As such, of major 
importance is the rapid creation of an appropriate knowledge structure easily accessible on the Web, encoding 
the most up-to-date information regarding the new disease, and capable of easy, continuous updates from the 
various medical communities working on the disease understanding and relief. 
A Holonic Diagnosis System for e-Health applications was proposed by Ulieru [24]. It consists of a 
medical holarchy, Figure 1, that is a community of people and/or virtual entities (hospitals, clinics, databases, 
medical devices) committed to a common information-dependent goal (e.g. to contain and control a new 
epidemic, such as SARS). In virtue of its ability to self-organize [25] the holonic diagnosis system is capable 
to cluster all the resources  to be involved in diagnosis, prediction and progression monitoring of the disease 
at stake and manages the flow of information and interactions throughout the holarchy according to the 








Figure 1: Medical Holarchy 
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Medical holarchies, Figure 2 can act as a primary response to the needs and requirements of today’s 
healthcare system, especially to the need for unimpeded access to healthcare services and ease of workflow 
management throughout the medical system.  Moreover, backed by a solid search mechanism and a consistent 
knowledge gathering and representation engine, the system can dynamically retrieve information and create 
new knowledge to support the continuous discovery of treatments for new diseases [9], or the immediate 
access to vital information in case of an emergency. During an e-Health rescue operation, novel e-Health 
technologies can be used, e.g. for patient care authentication by a wireless fingerprint sensor that accesses 
their profile from a remote database which can be accessed via the e-Health (support) holarchy [24].  
Depending on indicators such as blood pressure and the health history of the patient, a first diagnosis is 
compiled using automated decision support systems [26]. Electronic logistics support provides information 
about the next available and suitable hospital, initiate staff assembly and emergency room preparation, and 








Figure 2: e-Health Holarchy 
Planning and scheduling of resources on all levels of the e-Health holarchy enables reconfiguration and 
flexibility by selecting functional units, assigning their locations, and defining their interconnections (e.g. 
reallocating hospital beds to cope with the victims, finding the nearest hospital with the appropriate facilities, 
respectively medical specialists, etc. 








Testing Machine Holarchy (Basic System 




With the advent of the Semantic Web [33] the WWW world is evolving from a simple a repository for 
information, towards a distributed, collaborative, and high-volume computing environment that poses 
particular new challenges to the efficient and effective design of data and transactions. To make the 
information more accessible using machine-readable meta-data there have been several research efforts of 
which ontology engineering is a key component. A body of formally represented knowledge is based on 
conceptualization, namely an abstract, simplified view of the world that we wish to represent for some 
purpose, usually involving computers. It consists of a set of objects, concepts and other entities about which 
knowledge is being expressed (often called the universe of discourse) and of relationships that hold among 
them. Every formal knowledge model is committed to some conceptualization, implicitly or explicitly. An 
explicit specification of this agreed conceptualisation is called ontology [8].  
A shared ontology defines a common understanding of specific terms together with their relationships and 
rules of use, in order to allow communication between systems on a semantic level. Classical techniques and 
methodologies are largely inadequate because of the inherently autonomous and heterogeneous nature of the 
information resources, which forces applications to share data, respectively services, often without prior 
knowledge of their structure respectively functionality. Computer based ontologies may be seen as shared 
formal conceptualization of domain knowledge and therefore constitute an essential resource for enabling 
interoperation in an open environment supported by the OHDS on the Web.  
The Ontology-based Holonic Diagnostic System (OHDS) [9] sets up on knowledge discovery from 
ontologies, such as medical issues, health matters, disease factors, DNA etc, and knows who is doing a 
particular research, what work has been done and which research group has the most up-to-date results, which 
database on the web is needed, what is in it, what is the value of the information in that database, where it fits 
into the specific disease knowledge and how to access it, who’s work are related to each other or overlapping 
with each other or complementary to each other etc. It supports searches, translations, categorization, 
indexing (through ontology and agents), downloads, uploads and correlates disease information to 
dynamically create knowledge for the diagnosis, control and treatment of new, unknown diseases.   
In this paper we build on these previous results in the development of medical holarchies by strengthening 
the knowledge organization using latest advances in ontology design and development. 
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2. STATE-OF-THE-ART IN e-HEALTH ONTOLOGY DEVELOPMENT 
 
The development, dissemination and utilization of common communication standards, vocabularies and 
ontologies [18] for health care is a very hot research topic, given the proliferation of e-Health technologies. 
There are several consortia in which IT specialists join forces with medical experts to develop such standards. 
The EU’s CEN/TC 251 aims is to achieve compatibility and interoperability between independent systems, to 
support clinical and administrative procedures, technical methods to support interoperable systems as well as 
requirements regarding safety, security and quality. The US standardization bodies, the American Society for 
Testing and Materials’ Committee on Healthcare Informatics (ASTM E31) and Health Level Seven (HL7) are 
involved in similar work. ASTM E31 is developing standards related to the architecture, content, storage, 
security, confidentiality, functionality, and communication of information while HL7 is mainly concerned 
with protocol specifications for application level communications among health data acquisition, processing, 
and handling systems. 
Bioinformatics and health care informatics are fields that already have active communities developing 
ontologies, yet the application of such ontologies as GALEN [30], Unified Medical Language System 
(UMLS) [3], Systematized Nomenclature of Human and Veterinary Medicine (SNOMED), has lagged behind 
their potential, despite the huge drive by health care professionals to bring bioinformatics and health care 
information into clinical workstations and onto the Internet. The main reason appears to be that these existing 
ontologies are being developed to meet different needs, each with its own representation of the world, suitable 
to the purpose it has been developed for. There is as yet no common ontology. Of those that are being 
developed, GALEN provides a common terminology that is currently of limited scope, while UMLS lacks a 
strong organizational structure, and SNOMED provides only diagnosis nomenclature and codification [32].  
Other ontology based bioinformatics work includes the Riboweb ontology [1], the Gene Ontology (GO) 
[7], the TAMBIS Ontology (Transparent Access to Multiple Bioinformatics Information Sources) [21], and 
L&C’s LinkBase®. 
TAMBIS, uses ontology to enable biologists to ask questions over multiple external databases using a 
common query interface. 
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LinKBase® by L&C incorporates recent results involving a very large commercially available formal 
domain ontology. It is reported [17] to currently contain over 5.000.000 knowledge entities of various types: 
concepts, relationships, terms etc. These entities represent medicine in a way that can be understood by 
algorithms. Consistency is maintained through a description-logic based knowledge system called 
LinKFactory®. 
While neither Riboweb, Gene or TAMBIS Ontology deal with human diseases and do not answer disease 
questions, the LinKBase project has been commercialized and is not available for everyone. The application 
domain of human disease research and control involves resources of medical, genetic, environmental and 
treatment data. A characteristic of the domain is that trusted databases exist but their schemas are often poorly 
or not documented for outsiders, and explicit agreement about their contents is therefore rare.  
 
For this reason, we adopted the ontology design methodology of DOGMA (Developing Ontology-Guided 
Mediation for Agents) [16].In this approach database schema elements, as well as linguistic elements are 
represented as lexons combining the knowledge domain. Knowledge about their usage (such as constraints, 
rules, etc.) is kept rigorously separate and is specified as part of the formal commitment of an application to 
these lexons. This so-called double articulation permits a high degree of scalability, an essential requirement 
for agent-based computing. A second fundamental aspect of DOGMA is that it distinguishes data models 
(which are embedded in specific applications) from proper ontologies (this should be application-
independent) [5], [20]. The mapping of a data model to an ontology (in DOGMA) precisely constitutes its 
formal semantics, in fact reified as part of a commitment. 
3. INFORMATION RESOURCES FOR OHDS 
 
Medical researcher teams are heterogeneous. No single institution has all the required resources or skills 
and team members capable to cover all the health related issues at the global health level (such e.g. new 
epidemics). Hence the OHDS should enable resources sharing and usage co-ordination in dynamic, virtual, 
multi-institutional organizations by accessing remote data sources like stored medical and biological 
information in large quantities. But it would be very time consuming to evaluate the information from each 
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database one may need, such as where it fits into the whole knowledge world and how one can access it. This 
is where ontologies are needed as a means to capture and represent in the computer knowledge shared by all 
people in a certain community. For example, one could want to combine a medical data source in Europe with 
a biological data source in China in order to perform an analysis. Firstly, we need the OHDS services to 
provide a dynamic way to use dispersed heterogeneous resources and services in such a large distributed 
scientific environment. For this we have developed a soft computing methodology that will be presented in 
subsection 3.1. Secondly, we need a way to describe data and resources in a way that is understandable and 
usable by the target community. For this we have developed generic templates [10], named generic human 
disease ontologies (GHDO) from which specific templates, named specific human disease ontologies (SHDO) 
can be derived by the OHDS framework. The GHDOs and SHDOs will be described in subsection 3.2, the 
OHDS framework is presented in section 4 while the OHDS mechanism will be detailed in section 5. 
3.1. Soft Computing Framework for Heterogeneous, Dispersed  
Medical Knowledge Integration 
 
As a post internet framework, the OHDS enjoys an unusually large number of high-quality, complex, but 
extremely heterogeneous information resources, which furthermore are often made available through site-
specific services only. For the integration of the heterogeneous knowledge gathered from various sources we 
have developed a consensus analyzer designed using soft computing technology [26]. 
The contribution of several knowledge sources to the development of a knowledge base brings enormous 
value, but at the same time it presents a big challenge to the knowledge engineers.  Communication between 
dispersedly located expert sources has to be supported by an adequate interface, various expert opinions have 
to be reconciled, eliminating contradictions and choosing the most encompassing solution in each case, 
privacy and security issues have to be dealt with adequately [14], etc.  
To cope with this we propose a methodology capable to integrate disperse heterogeneous sources of 
knowledge into a unified ontology-based template. The methodology consists of the following steps: 
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Find the patterns for the disease at stake. This will determine the backbone on which the gathered 
knowledge will be structured. 
Reconcile the differences between various knowledge sources. The differences are investigated using an 
automatic consensus analyzer capable to determine where these differences occur and reconcile them by 
embracing both views within a broader, more generic rule/template.  
Determine and Test the Core Rule Set. The result of this reconciliation process will be a core template for 
human disease ontology encoding fundamental diagnostic knowledge regarding a particular disease.  
 
Each time a discrepancy between the existing template and a new knowledge source is encountered  both 
the template and the new source are analyzed by the Consensus Analyzer which evaluates the ‘distance’ 
between them and the point of minimum consensus (the point of maximum conflict) – where the template and 
new source clash most.  To evaluate this distance we use soft competitive learning [6].  
 
Suppose we are developing consensus in a universe X = {x1, x2, ...,xn}; a fuzzy relation R of order n will 
have elements rij encoding the preferences given to xi relative to xj. rij = 1 implies that alternative i is 
definitely preferred to alternative j. At the other extreme we have maximal fuzziness, where rij = rji = 0.5. 



















      (2) 
where tr is the trace and T is the transposed of the matrix. The measure F(R) averages the joint preferences 
in R over all distinct pairs in the Cartesian space X x X. F(R) is proportional to the fuzziness or uncertainty 
about pair wise rankings. Conversely the measure C(R) averages the individual dominance of each distinct 
pair of rankings.  
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The two measures are related: 
 1)()( =+ RcRF       (3) 
 
Measures of preference can be useful in determining consensus. We define three type of consensus as 
follows: 
Type I consensus: There is a clear choice, say alternative i (the ith column is all zeros) and the remaining 
(n-1) alternatives all have equal secondary preference (i.e 1/2). 
Type II consensus: There is one clear choice say alternative i but the remaining (n-1) alternatives all have 
definite secondary preference (i.e 1). 
Type Fuzzy consensus: Occurs when there is a unanimous decision for the most preferred choice, say 
alternative i but the remaining (n-1) alternatives have infinitely many fuzzy secondary preferences. 
 
From the degree of preferences measures given in previous equations we can construct a distance to 
consensus metric defined as 
 
 2/1)1)(2(1)( −⋅−= RCRm     (4) 
 
Where: 
 2/1)/2(1)( nRm −=   
 for a Type I consensus relation      (5) 
 
 0)( =Rm  
 for a Type II consensus relation (6) 
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When n > 2, the distance between Type I and Type II consensus increases with n as it becomes 
increasingly difficult to develop a consensus choice and simultaneously rank the remaining pairs of 
alternatives. The value of distance to consensus quantifies the dynamic evolution of a group as the group 
refines its preferences and moves closer to a Type I or Type II or Type Fuzzy consensus. The vast majority of 
group preference situations eventually develop into Type Fuzzy consensus, Types I and II being typically 
only useful as boundary conditions. 
 
The consensus analyzer works with consensus rooms. Each room represents a topic on which the 
knowledge needs to be reconciled. As an example, in Figure 3 we present a consensus room designed for the 
development of a standardized knowledge base for glaucoma progression monitoring/follow-up. Consider that 
some experts access the system via the web on a secured internet ring. Once the expert has selected the 
consensus room, the system will provide her/him with the case data, that is, all the input variables used by the 
intelligent algorithm and its fuzzy rules. 
 
The possible Follow-up alternatives are presented together with the input variables. Those alternatives are 
extracted from the expert system in order to present to the expert only with the feasible ones. 
 
The lower part of the screen shows the ranking matrix (a fuzzy relation) that the expert should fill in with 
his/her preferences about the alternatives, as a pairwise comparison. All the opinions are aggregated using 
fuzzy weighted aggregation operators. The already mentioned two very simple aggregation methods are the 
max (optimistic combination) and the min (pessimistic combination). We use here the max aggregation 
operator, that is, the optimistic combination. 
 
A Final Relation R is obtained from this step. This fuzzy relation R of order n will have elements rij 
encoding the preferences given to xi relative to xj. rij = 1 implies that alternative i is definitely preferred to 






Figure 3: Consensus Room 
 
 
The value of distance to consensus quantifies the dynamic evolution of the group of experts as the group 
refines its preferences and moves closer to a Fuzzy consensus.  
The system has a predefined distance to consensus independent from the case being analyzed. We defined the 
distance to be 90%. Finally when  the distance to consensus predefined is reached, the rule is integrated in the 





Figure 4: Current Consensus and Threshold Determination 
 
For the Example in Figure 4: 
 
Consensus Room: Mister X 
Input Variables: Under _treatement: NO; IOP (Intra Ocular Pressure):  low; CD_Ratio: abnormal; 
Glaucomatous_CD: Yes; Visual Field: Early Loss 
Alternatives:  A1: Within 1 month; A2: Within 2 months; A3: 1 Week; A4: 3 to 6 Months 
 
Doctor 1 Ranking: A1-A2: Absolutely Preferred; A1-A3: Absolutely Preferred; A1-A4: Absolutely 
Preferred; A2-A1: Absolutely Not Preferred; A2-A3: Equal Preferred; A2-A4: Equal Preferred; A3-A1: 
Absolutely Not Preferred; A3-A2: Equal Preferred; A3-A4: Equal Preferred; A4-A1: Absolutely not 
Preferred; A4-A2: Equal Preferred; A4-A3: Equal Preferred; 
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Doctor 2 Ranking, The follow-up alternatives comparison results in: A1-A2: Absolutely Preferred; A1-
A3: Absolutely Preferred; A1-A4: Absolutely Preferred; A2-A1: Absolutely Not Preferred; A2-A3: Equal 
Preferred; A2-A4: Equal Preferred; A3-A1: Absolutely Not Preferred; A3-A2: Equal Preferred; A3-A4: Equal 
Preferred; A4-A1: Absolutely not Preferred; A4-A2: Equal Preferred; A4-A3: Equal Preferred; 
The ‘Absolutely’ preferred option having the max value, we obtain the R fuzzy relation applying the max 
operator to each opinion, so Alternative 1 is the choice of the two doctors. Then we get the F and C values to 
0 and 1 respectively, so finally M will be  equal to 1, that means 100% of consensus. 
Based on the consensus metrics, the ontology template is tuned to embrace all opinions as much as 
possible. This means that the rules obtained will be positioned in the equidistant point to all expert opinions. 
Once the distance to consensus predefined is reached, the rule is integrated in the knowledge base. In case of 
strong discrepancies between the actual template and the new knowledge source, the generated rule may not 
make sense as its generality may render it useless. However, this will not affect the system overall, as the rule 
will be implicitly overlooked by the fuzzy reasoning process. 
3.2. Ontologies as Patterns of Medical Knowledge 
 
In our vision ontologies can effectively integrate distributed world wide research in the area of disease by 
aligning and merging relevant information from publications and medical databases, DNA and protein 
databases, research institutes, health departments, hospitals etc. As such, the OHDS can provide the required 
distributed collaborative platform as well as easy access to resources. We designed the Generic Human 
Disease Ontology (GHDO) as a template with four main branches [10], Figure 6: (1) types, describing 
different types of a disorder; (2) phenotype, describing symptoms of a disease; (3) causes responsible for that 
disorder which can be environmental and/or genetic; (4) treatments, giving an overview of all treatments 
possible for that particular disease as well as treatments efficiency. This template helps to produce Specific 
Human Disease Ontologies (SHDO) as it will be illustrated in section 6. The ontology explains (Figure 6) that 
a disease may have (1) different types which also may be further divided into subtypes etc. Each disease is 
caused by (3) cause(s) which can be genetic (genotype) or environmental. Genetic causes can be a mutated 
gene, a complex of genes or a region in the DNA sequence that potentially contains a gene responsible for the 
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disease and needs to be further examined. Environmental causes can be: viruses/bacteria, stress, climate, 
drugs or family conditions. For each disease, there is (2) corresponding phenotype namely, observable 
characteristics of an ill individual and (4) treatments possible for the disorder that can be drug therapy, 
chemotherapy, surgery, psychotherapy or physiotherapy. 
Another major advantage of using the holonic structure is that it respects complete autonomy of the 
existing ontology nodes. Each of the existing nodes can withdraw or join the holarchy whenever it is 
necessary [11]. This is very important when generating on request Specific Human Disease Ontologies as we 
will show in Section 6. 
Figure 5 shows a pictorial representation of the information integration from different sources world-wide. 
The retrieved information is organized within the Generic Human Disease Ontology and its four different 
dimensions. The proposed solution enables researchers to analyze the different factors, the relationships 
between them and different types of diseases simultaneously. After analysis and combination of the 
information, the result is presented in a way that makes it easier for the user to have an overview of the up-to-











Figure 5: Combining the information from different databases worldwide into the four dimensions of Generic 
Human Disease Ontology (GHDO) Template Pattern 
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4. PRINCIPLES OF BUILDING GENERIC HUMAN DISEASE 
ONTOLOGY (GHDO) 
 
Ontological commitments are formal agreements (expressed in DOGMA as views, rules, and constraints 
[16] ) to use the shared vocabulary in a coherent and consistent manner. Shared vocabulary is different for 
different knowledge domains. Our knowledge domain is going to have its own vocabulary written in an 
ontological lexicon. An ontology base consists of lexons, expressing (usually linguistically derived) facts 
between terms. Terms are often organized hierarchically in taxonomy, by promoting the subsumption fact into 
an implicit, special, and axiomatically defined relationship. Facts in DOGMA are always true only within a 
context, defined for any lexon as carried by an identifiable source, usually a document. 
In Figure 6, we show the four main branches of the GHDO. Of course, terms within the GHDO are much 
more numerous than shown and are validated for existence against concepts from a biomedical lexicon such 
as e.g. UMLS Metathesaurus [3].  
We first illustrate the notions of commitment as a constrained interpretation and of (first order) well-
formed formula (wff) through examples. Consider a vocabulary V = (T, R) where T is a set of terms denoting 








Fig. 6: Generic Human Disease Ontology and its four main subontologies: type, phenotype (symptoms), cause 
and treatment. 
For illustration we will develop a small generic ontology representing the main concepts, identified in a 
given (implicit) context. Let T = {disease, type, subtype, sub-subtype, phenotype, treatment, drug therapy, 
chemotherapy, physiotherapy, surgery, psychotherapy, cause, genotype, gene, gene complex, DNA region of 
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interest, environment, stress, climate, family conditions, drugs, micro-organism, bacteria, virus} that  
represent the lexicon of user’s world of diseases, and  R = {has, isof, isa, is caused by, is responsible for, is 
cured by, cures, shows, characterizes} that represent relationships (roles) for this domain. Within DOGMA 
Modeler, the object-relation model (ORM) [12] notation is also used to represent relationships and 
commitments such as “each disease is caused by at least one cause” and “each disease shows at least one 
phenotype”.  The relationships can be represented through the following binary relations, called lexons or 
facts:  
• has (disease, type); isof (type, disease);  
This means that “disease has a type” and “type is of a disease”. 
• shows (disease, phenotype); characterizes (phenotype, disease);  
This means that “disease shows a phenotype” and “phenotype characterizes a disease”. 
• is caused by (disease, cause); is responsible for (cause, disease);  
This means that ”disease is caused by a cause” and  “cause is responsible for a disease”. 
• is cured by (disease, treatment); cures (treatment, disease); 
This means that ”disease is cured by a treatment” and “treatment cures a disease”. 
5. HOLARCHIC STRUCTURE AND MECHANISM 
 
In this section, we illustrate how ontologies can be dynamically developed for the knowledge domain of 
biomedical and bio-engineering research, using the OHDS framework. 
In case of knowledge collection, manipulation, organization and discovery for human diseases the 
proposed OHDS framework can be very useful [9]. The holonic structure (Figure 7) is a nested hierarchy of 
four holarchies  in which each of the four GHDO dimensions template is associated with one holarchy. By 
sending a request to the Mediator Agent of the OHDS the process is started. From there it infiltrates the 
hierarchy till it reaches the leaves. The record is interpreted and analyzed at the higher levels of the hierarchy 












Figure 7: OHDS structure 
 
HOLARCHY MEDIATOR AGENTS (HMA) 
Each holarchy has a single entry point, named Mediator Agent. The OHDS has as main entry point the 
Disease Mediator Agent and in turn each branch has its own mediator agents, respectively Types, Symptoms, 
Causes and Treatments Mediator Agents. Their task is to decide what other subordinate Disease Specialist 
Agents - DSAs or Disease Representative Agents – DRAs need to be activated in order to retrieve the 
information requested by the user. Another task is to integrate the retrieved information coming from DSA via 
DRA in another direction.   
 
DISEASE MEDIATOR AGENT (DMA) 
The DMA interacts with the user and decides which of the four holarchies needs to be deployed in order to 
generate SHDO requested by user. For example, sometimes a user may be interested only in causes of a 
disease so that there is no need to deploy Types, Symptoms or Causes holarchy.  Also, each of the four 
holarchies has significant databases assigned to it. Some databases contain information only regarding for 
example, symptoms of a disease so that, e.g. there is no need for agents from the Cause holarchy to visit those 
databases. Another task of the DMA is to combine the information coming in another direction from the four 
holarchies and present it to the user as a single unit. 
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DISEASE SPECIALISTS AGENTS (DSA) 
Holarchy inner nodes represent Disease Specialist Agents (DSAs). They represent decision makers and are 
specialists on a specific dimension of GHDO. We differentiate Types, Symptoms, Causes and Treatments 
Diseases Specialists Agents (Ty-DSA, Sy-DSA, Ca-DSA and Tr-DSA). Each DSA will focus on a task which 
corresponds to its level of knowledge namely, after subordinate agents (DRAs) have returned their data it 
interprets, compares, and evaluates them in order to define a proper ranking among all the delivered data. The 
ranking is done by the HMA using two different types of matching as it will be described further. An 
important task of a DSA is to interpret the incoming data and come to a conclusion on whether there is 
sufficient evidence for the likelihood of a specific disease. If not, the DSA has to decide - on the basis of the 
delivered information - whether it makes sense to consult other DRAs or, if this seems to be unpromising, 
whether to advertise the request on the Internet. This is especially promising if there is suspicion that the 
disease is a so far unknown or imported one, thus one that is very rare in the living space of the 
patient/medical unit.  
 
DISEASE REPRESEANTATIVE AGENTS (DRA) 
The leaves are so-called Disease Representative Agents (DRAs). We differentiate Types, Symptoms, 
Causes and Treatments Diseases Representative Agents (Ty-DRA, Sy-DRA, Ca-DRA and Tr-DRA). Each 
DRA is an expert on a lower level concept within GHDO. Note that DRAs differ from DSAs in that they need 
to recognize the significant information inside the appropriate database and retrieve that information. This 
information is then passed over to the DSA which will do the analysis and comparison of the retrieved 
information so that only “new” information will be passed over to the respective mediator agents. For 
example, article_1 claims that a gene located somewhere on chromosome 6 is responsible for a disease in 
question, while article_2 gives more precise information  regarding the gene of interest such as location 6p11-
p17. Ca-DRA retrieves both articles while Ca-DSA passes over only information from article_2 to the CMA. 
CMA will do the matching and assign the value ‘6p11-p17’ to the concept ‘DNA region of interest’, telling 
the user that the DNA sequence positioned on chromosome 6 between p11 and p17 potentially contains a 
gene which may be causing the specific disease. In this way we keep the presented information updated and 
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also do the selection of the information before presenting it to the user and present only the key-information. 
This is especially important when lots of information regarding a specific topic is available. 
 
THE HOLARCHIC MECHANISM 
For the information integration process, the Holarchy Mediator Agents perform two different types of 
matching. First one is matching of the template of GHDO with the incoming information and assigning values 
to the concepts from GHDO (for example, to assign the name ‘GRK3’ to the concept ‘gene name’ from 
GHDO.) In its decision process on what to do with all the input that may be provided by the lower level 
agents the Disease Mediator Agent (DMA) not only relies on its knowledge but also on the experiences it 
made in the past. For this reason, latest version of SHDOs regarding the same disease requested by some 
other user before, are saved in a pattern store, making it possible to do the second type of matching. If a 
difference is found, the new SHDO should be checked for its consistency. If the difference is consistent, the 
latest version should be saved and used next time for matching.  The DMA needs to be enriched with 
sufficient knowledge/intelligence to be able to interpret the incoming information and also to relate it to its 
knowledge/experience. Moreover, it may be that relevant data/examinations are missing and that more 
information may be needed and thus lower level agents need to be activated until the process is completed. 
The achieved results can have different levels of certainty. In the best case, the information that was 
provided to the DRA and combined together by Mediator Agents, provides all the data and information that is 
needed in order to conduct a comprehensive search on the SHDOs as requested by the user. In less fortunate 
cases the Electronic Health Record (HER) may only provide a part of the optimal set of information and data 
requested. In such a case where the already available information in the SHDO does not exclude a disease, the 
result of its analysis comes with a set of tasks, examinations, and tests that are suggested to be performed by 
the medical institution in order to further verify (or invalidate) the hypothesis.  
6.  HOW DO THE GHDO AND OHDS WORK TOGETHER 
 
The conceptual framework of our OHDS methodology and prototype is based on the formal theory of 
ontology described in section 4. The system extracts relevant information from publications and medical 
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databases, DNA and protein databases, research institutes, health departments, hospitals etc. Upon the 
analysis and combination of the information, the result is presented in a way that makes it easier for the user 
to have an overview of the up-to-date knowledge about a specific disorder. Use of ontologies provides us with 
a more controlled and systematic way to perform information retrieval.  Moreover, the holarchic/nested 
organization of ontologies enables implicit inheritance which adds taxonomical context to search results, 
making it easier for the researcher to spot conceptual relationships in data.  The latter fact is important for 
instance in the case of complex human disorders where one looks for relationships between different factors 
that are simultaneously responsible for each of the many types of disorders. 
The GHDO links the user to multiple heterogeneous information resources via its four main branches. 
Each mediator agent in the GHDO template (Figure 7) has a consensus analyzer (recall subsection 3.1.) that 
supports the OHDS to integrate the dispersed knowledge on each branch of the holarchy into the SHDO 
relative to the case/disease investigated. In this way, using the GHDO the OHDS can derive SHDOs on 
request. The SHDOs are specified and generated when a user queries the system. 
The source information covers different areas of interest with respect to human diseases in order to allow 
different user categories (each having specific intentions), to query the system. Researchers are constantly 
searching for and adding more information to the already existing pool of knowledge regarding a particular 
disorder. Physicians are directly in contact with patients and are using all significant information to help and 
treat the patients. Especially when a new disease epidemic starts spreading, researchers and physicians are 
strongly connected because they are working towards the same goal, but on different knowledge levels. 
6.1 Ontology as Support Tool for Physicians 
 
If a medical professional queries the system, she/he will mainly be interested in two of the four 
components of our system, namely symptoms and possible treatments of a particular disorder. There are some 
exceptions to this rule, such as in the next use case, when a new disease is encountered by the physician. 
 
Use case 1: Physician cannot identify the disease. A physician may have a patient showing some 
symptoms of a disease but he may not be able to say what kind of disease it is. At this stage, it is 
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recommended to keep as many as possible components involved in the search: symptoms (phenotype), causes 
and treatments. In this case, the derived Specific Ontologies have the “phenotype”, “cause” and “treatment” 
branches. By entering the symptoms into the system, the doctor may be able to retrieve the information 
regarding that disease. It is also possible that different diseases are showing the same or similar symptoms, 
such that the physician retrieves more than one SHDO as we show in Figure 8. In such a case, it may be 
useful to look for some significance in the causes of the disorders, as we explain in the sequel. 
 
Use case 1_a: causes of the disease are not known. On the basis of the key symptoms the doctor will chose 
one (set of) disease(s). This disease becomes the doctor's working hypothesis, her/his most likely choice. The 
doctor then starts to gather evidence in support of the working hypothesis, always keeping in mind the set of 
alternative hypotheses. Such a process relies on all kinds of information, e.g., information that is gained by 
interrogating the patient or by conducting necessary (physical or instrument- or tool-based) examinations and 
tests. It will be assumed that all this data and information will be stored in so-called medical records for 
patients or patient records for short, which follow the GHDO template. It will be assumed that all 
necessary/available medical information about a patient is kept in exactly one comprehensive computer 
readable patient record that is a set of SHDOs for the specific conditions of the particular patient. This enables 
the patient record to be processed by agents because the ontology assigns the unequivocal semantics to the 








Figure 8: Two different diseases caused by mutations of different genes and treated by different methods showing 
same symptoms 
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Use case 1_b: cause of the disease is known, e.g. a  gene mutation. For example, in case of disease_1, 
gene_1 is mutated and thus causes this disorder. And disease_2 is caused by mutation of gene_2. The 
physician can do the screening of the patients’ DNA to check if gene_1 or gene_2 is mutated. If mutation 
found in gene_1, the patient has disease_1 and if gene_2 mutated the patient suffers from disease_2.  
Only when the patient is correctly diagnosed, the physician may consider possible treatments for the 
patient. Our information system therefore also reduces the risk of misdiagnosis. 
 
Use case 2: Physician can identify the disease and wants to consider possible treatments. It is 
common that there may be more than one (drug) treatments possible for a particular disease (see Figure 9). A 
physician will wish to look at all the options possible before choosing one. Choosing medication is also a 
personal thing because not all people respond in the same way to same medication. At this point a medical 
professional might for instance consult our ontology-based information system to do a one-component search 













Figure 9: Different drugs target same disease 
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6.2. Ontology as Support Tool for Research 
 
The biomedical researcher using our system may be interested in one specific of the four possible 
components of our system. E.g. a researcher working on drug discovery would be more interested in the 










Figure 10: Genetic causes of manic-depression (current research) 
 
Use case 3: Researcher examines possible causes of a disorder. Often not all the causes responsible for 
a particular disorder are known, e.g. in the case of manic-depression (Figure 10). By querying the OHDS and 
getting back significant information systematically represented, the researcher is able to identify some regions 
of interest in the DNA sequence such as regions 2p13-16, 10q21-24, 12q23-24, 17q11-12 and Xq24-26 on 
chromosomes 2, 10, 12, 17 and X respectively [2], [4], [13], and [15]. Those regions need to be further 
examined in order to find a gene and a mutation inside that gene.  
If a new gene is found on one of the already identified DNA regions of interest, our model will now have 
four instead of five instances of the term “DNA region of interest” and one more instance of the term “gene” 
(see Figure 11). Given the length of the DNA sequence it is obviously much easier for a researcher to target a 
specific area of a chromosome such as 2p13-16 than the whole chromosome 2. Further research, may allow 
her/him to narrow down the region of interest to, for example 2p14-15. Because of the agreed semantics in a 
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shared ontology it will be easier for the next person to continue the research in the same direction and 
possibly to locate the gene of interest. This aspect of cooperation between different teams increases 











Figure 11: Genetic causes of manic-depression, future research if gene of interest found on chromosome 2 
7. IMPLEMENTATION VISION 
 
The proposed OHDS will support the doctors in the diagnostic, treatment and supervision processes of the 
evolution of new epidemics, based on the exploration of all data pertinent to each case and on the scientific 
data contained in various professional databases. From an architectural perspective, the OHDS (Figure 12) 
consists of an Education&Consultation System [28] to provide evidence-based guidelines of care to clinicians, 
and the Consensus Analyzer [26] to constantly update and refine these knowledge templates based on as new 
knowledge sources are parsed. Users will access the OHDS directly via a Web-based user interface, or 
indirectly by using their clinical system. The OHDS is also integrated with other electronic health information 
infrastructure services, such as patient and provider registries. In addition to structured data, the OHDS 
system uses high-resolution diagnostic imaging supported by various networking infrastructures. The medical 
specialist will interact in real-time with the various data collected, unified, and explored by the OHDS agents. 
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With respect to the reconciliation of standards of care we are working on the creation of an R-MIM for the 
OHDS based on the HL7 e-Health communication standard [29].  
 
 
Figure 12: Solution Domain Architecture 
 
In a medical holarchy such as our OHDS a major challenge is to develop scalable, secure web based 
services where the security and privacy framework is meant for the access to and the protection of sensitive 
information as it travels across the boundaries of individual organisations, in compliance with the Privacy of 
Information Act [31]. Therefore the major implementation concern is the secure web-data manipulation by 
medical specialists, while dealing with patients affected by diseases calling for a highly specialized 
knowledge and expertise. In this context a platform able to interact with a plethora of databases and other 
forms of information storage and retrieval methods is a must. The interaction of doctors with the information 
has to be secured through encryption and through a complex process of authentication and authorization. 
Some of the required security technologies have already been developed for other industries, e.g., in the area 
of electronic commerce. Other technologies such as patient-consent dependent role-based access control and 
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person-oriented audit trails are not readily available to date. We are currently working on the system 
implementation – for more details see [29]. 
8. COMPARISIONS, DISCUSSION AND CONCLUSIONS 
 
In this paper an ontology-based holonic diagnostic system was presented that unifies the advantages of 
multi-agent system technology with those of an integrated ontology for the purpose of representing the active 
knowledge about human disorders. The self-organizing, emergent behavior of the resulting system supports 
the medical researcher/specialist, especially in cases in which the kind of disease the patient is suffering from 
is not certain or easily diagnosable. The ontology-based development supports the containment and control of 
new diseases by enabling dynamic knowledge discovery as follows: 
• a computer-based ontology supports the work of scientists in gathering information on highly 
specific research topics of human disorders, and allows users on a world-wide basis to 
intelligently access new scientific information much more quickly; 
• shared knowledge improves research efficiency and effectiveness, as it helps (a) to avoid 
unnecessary redundancy in doing the same experiments, such as the examination of the same 
region of a DNA sequence, and (b) the determination of, e.g. which part of DNA sequence needs 
to be further examined in order to find the gene responsible for a disease; 
• ontologies are the basis of interoperation, by allowing distributed but autonomous and 
heterogeneous resources to function in a world-wide cooperative environment: this makes it 
possible to split effectively a big task between different research teams; 
• constructing the data patterns which combine different genetic and environmental causes and 
different disease types, will facilitate the sorting out of the exact combinations of the genetic and 
environmental factors involved as well as their individual influences on a specific complex 
disease type such as e.g. depression, thereby assisting medical professionals to diagnose, treat and 
possibly prevent the disorder. 
The four “dimensions” (phenotype, cause, treatment and type) are each built for a different purpose and are 
orthogonal to each other. The “Types” sub-ontology is more a classifying ontology and is strongly 
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hierarchically supported. It does not provide a user with much scientific information. This ontology is based 
on classification. The “Phenotype” sub-ontology is more descriptive than the others and is based on 
observation and diagnosing characteristics of the ill individual. The “Cause” sub-ontology is providing a user 
with scientifically proven facts and is strongly based on scientific research. The “Treatment” sub-ontology is 
a combination of classifying and research ontology. Modeling available treatments is research work but, for 
example all the discovered drugs can be further hierarchically classified. All four “dimensions” are different 
from each other and each “dimension” is unique. But jointly they give an overall picture and a good overview 
of knowledge about a human disorder. 
The holarchic structure (Figure 7) provides the required distributed collaborative platform as well as easy 
access to resources. In the case of human diseases, we use the research publications and medical databases, 
DNA and protein databases, research institutes, health departments, hospitals etc as information resources. 
The specific information requested by a user is aligned and merged into the GHDO which results in SHDOs. 
    The innovation in our work lies in the combination of holonic architectures, multi-agent technology for 
managing and subtracting un-structured bio-medical research results into structured disease information for 
end users and development of Human Disease Ontologies which act as spinal cord for the diagnostic system.  
Involving soft computing agents/holons to integrate dispersed knowledge sources into the ontology template, 
and by this refining the generic template via feed-back from the specific ones, results in a powerful 
mechanism for dynamic building of new knowledge, on the spot, as new epidemics emerge. In addition a 
reference model for secure health information processing was developed as a means for the OHDS 
implementation. So far we have developed complete upper and lower ontologies. However, lots of work still 
remains, such as implementation of local agent interactions, security concerns, upload the testbed system on-
line for testing and validation, test the Ontology and development of user view interfaces.  
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